Search clinical trials for: EA1080

Total 180 results

EA Pharma Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants

Healthy Volunteers

United Kingdom
Iuliu Hatieganu University of Medicine and Pharmacy

Unknown

Volemic Resuscitation in Sepsis and Septic Shock

Sepsis | Septic Shock | Hemodynamic Instability

Romania
Zhejiang Palo Alto Pharmaceuticals, Inc.

Recruiting

Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients

Chronic HBV Infection

China
Zhejiang Palo Alto Pharmaceuticals, Inc.

Completed

Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects

Chronic HBV Infection

China
Seoul National University Bundang Hospital

Completed

Effect of Goal-directed Fluid Therapy on Postoperative Complications

Liver Diseases | Pancreas Disease

Korea, Republic of
Smilebiotek Zhuhai Limited

Recruiting

QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration

Intermediate Age-Related Macular Degeneration

China
Stanford University

Completed

Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis (SA100)

Ulcerative Colitis

United States
Rambam Health Care Campus
Medispec

Completed

The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i (LI-ESWT)

Erectile Dysfunction

Israel
Royal Free Hospital NHS Foundation Trust
Acurable Ltd.

Recruiting

AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy

Sleep Apnea, Obstructive

United Kingdom
Rambam Health Care Campus
Medispec

Completed

The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders (LI-ESWT)

Erectile Dysfunction
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Hemodynamic Optimization During Major Urological Surgery (INTAT)

Hemodynamic Instability

Italy
The Cleveland Clinic

Completed

Hypotension Prediction Index for Blood Pressure Management (HPI)

Intraoperative Hypotension

United States
Rambam Health Care Campus
Medispec

Unknown

Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction in PDE5i Responders (LI-ESWT)

Erectile Dysfunction

Israel
Hansoh BioMedical R&D Company

Not yet recruiting

A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors

Non-Small Cell Lung Cancer | Solid Tumor

China
Temple University

Unknown

External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality (ArtAssist)

Critical Limb Ischemia

United States
Rambam Health Care Campus

Unknown

Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction

Erectile Dysfunction

Israel
Epimmune
Pharmexa A/S; Pharmexa-Epimmune

Unknown

A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) (EP1090)

HIV Infections

United States
Dita Aditianingsih

Completed

Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients

Hemodynamic Monitoring

Indonesia
Edwards Lifesciences

Completed

Assisted Fluid Management IDE Study (AFM)

Abdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular Surgery

United States
Samsung Medical Center

Completed

Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation

Liver Disease

Korea, Republic of
Rambam Health Care Campus

Unknown

Low Intensity Shock Wave Therapy (LI-ESWT) for Erectile Dysfunction in Post Radical Prostatectomy Patients Not Responding to PDE5 Inhibitors (LI-ESWT) (LI-ESWT)

Erectile Dysfunction

Israel
Rambam Health Care Campus

Unknown

Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms

Erectile Dysfunction

Israel
Chang Gung Memorial Hospital

Recruiting

Hypotension Prediction Index in Patients Undergoing Liver Transplantation

Intraoperative Hypotension

Taiwan
Erasme University Hospital
University of California, Los Angeles; University of California, Irvine; Bicetre...

Withdrawn

COntrolled MAp Trauma Brain Injury (COMAT Study) (COMAT)

Closed-Loop Communication

France
Erasme University Hospital
APHP

Withdrawn

Assisted Fluid Management in Patients Undergoing Major Abdominal and Orthopedic Surgery (AFM)

Goal Directed Fluid Therapy

France
CAMC Health System
Edwards Lifesciences

Unknown

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST) (FROST)

Critical Illness | Trauma

United States
Assistance Publique - Hôpitaux de Paris
University of California, Los Angeles; University of California, Irvine

Completed

Controlled MAP in the Brain Injury Patient (COMAT Study) (COMAT)

Brain Injuries

France
Myomo

Unknown

Myomo e100 NeuroRobotic System Home Safety Study

Stroke

United States
Tata Medical Center

Completed

Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery (RIGoROCS)

Ovarian Cancer

India
University of Jena

Completed

Effects of Soluble Phosphate in Humans

Healthy Volunteers

Germany
Myomo

Completed

Wearable Robotic Functional Assistance for Stroke Rehabilitation

CVA (Cerebrovascular Accident)

United States
Eisai Limited

Completed

A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)

Lennox-Gastaut Syndrome

Japan
Emory University
National Cancer Institute (NCI); Eisai Co., Ltd.

Recruiting

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Unresectable Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC... and other conditions

United States
Memorial Sloan Kettering Cancer Center

Completed

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Bladder Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection

Liver Cancer

United States
Emory University
Eisai Inc.

Terminated

Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer

Differentiated Thyroid Gland Carcinoma | Thyroid Gland Follicular Carcinoma | Thyroid Gland Papillary Carcinoma

United States
Attikon Hospital

Completed

HPI Index With GDHT in Predicting Hypotension In General Anesthesia Patients

Hypotension During Surgery

Greece
Guangzhou Lupeng Pharmaceutical Company LTD.

Active, not recruiting

A Study of LP-128 Capsules in Healthy Subjects

Chronic Hepatitis b

China
University of Cincinnati

Unknown

Robotic Brace Incorporating Electromyography (EMG) for Moderate Affected Arm Impairment After Stroke

Stroke

United States
Khon Kaen University

Recruiting

Cost-effectiveness of EGDT Using FloTrac/EV1000

Coronary Artery Disease

Thailand
Mayo Clinic
National Cancer Institute (NCI)

Completed

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Metastatic Adrenal Gland Pheochromocytoma | Malignant Adrenal Gland Pheochromocytoma | Malignant Paraganglioma

United States
Novo Nordisk A/S

Completed

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

South Africa, United Arab Emirates, India
M.D. Anderson Cancer Center

Recruiting

Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients

Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | Recurrent High Grade Fallopian Tube Serous Adenocarcinoma | Recurrent High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous Adenocarcinoma | Peritoneal High Grade...

United States
Assistance Publique - Hôpitaux de Paris

Completed

Impact of an Assisted Fluid Management System on Microvascular Parameters (MicroSupport)

Monitoring

France
M.D. Anderson Cancer Center

Recruiting

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditions

United States
Eisai Co., Ltd.

Completed

Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Japan, Korea, Republic of
Eisai Inc.

Completed

A Pharmacokinetic and Safety Study of E7080 in Subjects With Mild (10 mg), Moderate (10 mg), and Severe Hepatic Impairment (5 mg) and Normal Hepatic Function (10 mg)

Hepatic Impairment | Hepatic Function

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

Poorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Squamous Cell Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8

United States
Eisai Inc.

Completed

Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung

KIF5B-RET-Positive Adenocarcinoma of the Lung

United States, Hong Kong, Japan, Taiwan, Singapore
Eisai Inc.

Approved for marketing

An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

United States

Search clinical trials for: EA1080

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations